Erratum: The reverse evolution from multicellularity to unicellularity during carcinogenesis (Nature Communications (2015) 6 (6367) DOI: 10.1038/ncomms7367);The reverse evolution from multicellularity to unicellularity during carcinogenesis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Chen, Han ^a   Lin, Fangqin ^a   Xing, Ke ^a   He, Xionglei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CARCINOGEN; DISEASE TREATMENT; GENE EXPRESSION; HETEROGENEITY; LIFE HISTORY; MUTATION; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH RATE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CELLS BY BODY ANATOMY; CELLULAR PARAMETERS; DISEASE COURSE; DOWN REGULATION; EMBRYONIC STEM CELL; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; METASTASIS; MOUSE; MULTICELLULARITY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; UNICELLULARITY; ANIMAL; BIOLOGICAL MODEL; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; EVOLUTION; EXOME; GENETICS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; XENOGRAFT;

METAZOA;

ANIMALS; BASE SEQUENCE; BIOLOGICAL EVOLUTION; CARCINOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; EXOME; HETEROGRAFTS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84924359161     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9812     Document Type: Erratum

References (56)

1. Michod, R. E. & Roze, D. Cooperation and conflict in the evolution of multicellularity. Heredity 86(Pt 1): 1-7 (2001).
2. Grosberg, R. & Strathmann, R. The evolution of multicellularity: A minor major transition? Annu. Rev. Ecol. Evol. Syst. 38, 621-654 (2007).
3. Hammerschmidt, K. et al. Life cycles, fitness decoupling and the evolution of multicellularity. Nature 515, 75-79 (2014).
4. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
5. DeGregori, J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 71, 3739-3744 (2011).
6. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313 (2012).
7. Srivastava, M. et al. The Amphimedon queenslandica genome and the evolution of animal complexity. Nature 466, 720-726 (2010).
8. Davies, P. C. & Lineweaver, C. H. Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors. Phys. Biol. 8, 015001 (2011).
9. Sanchez Alvarado, A. Cellular hyperproliferation and cancer as evolutionary variables. Curr. Biol. 22, R772-R778 (2012).
10. Elena, S. F. & Lenski, R. E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 4, 457-469 (2003).
11. Sprouffske, K. et al. Cancer in light of experimental evolution. Curr. Biol. 22, R762-R771 (2012).
12. Vargo-Gogola, T. & Rosen, J. M. Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7, 659-672 (2007).
13. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
14. Miller, F. R. et al. Xenograft model of progressive human proliferative breast disease. J. Natl Cancer Inst. 85, 1725-1732 (1993).
15. Loeb, L. A. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer 11, 450-457 (2011).
16. Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
17. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013).
18. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
19. Lin, F. et al. Expression reduction in mammalian X chromosome evolution refutes Ohno's hypothesis of dosage compensation. Proc. Natl Acad. Sci. USA 109, 11752-11757 (2012).
20. Domazet-Loso, T. & Tautz, D. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol. 8, 66 (2010).
21. Li, L., Stoeckert, Jr. C. J. & Roos, D. S. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 13, 2178-2189 (2003).
22. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
23. Ostrow, S. L. et al. Cancer evolution is associated with pervasive positive selection on globally expressed genes. PLoS Genet. 10, e1004239 (2014).
24. Lang, G. I. et al. Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500, 571-574 (2013).
25. Danielsson, F. et al. Majority of differentially expressed genes are downregulated during malignant transformation in a four-stage model. Proc. Natl Acad. Sci. USA 110, 6853-6858 (2013).
26. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194 p 23-28 (1976).
27. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
28. Sole, R. V. et al. Can a minimal replicating construct be identified as the embodiment of cancer? Bioessays 36, 503-512 (2014).
29. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
30. Cooper, V. S. & Lenski, R. E. The population genetics of ecological specialization in evolving Escherichia coli populations. Nature 407, 736-739 (2000).
31. Qian, W. et al. The genomic landscape and evolutionary resolution of antagonistic pleiotropy in yeast. Cell Rep. 2, 1399-1410 (2012).
32. Olson, M. V. When less is more: gene loss as an engine of evolutionary change. Am J Hum Genet. 64, 18-23 (1999).
33. Merlo, L. M. et al. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 6, 924-935 (2006).
34. Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395-399 (2012).
35. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
36. Yates, L. R. & Campbell, P. J. Evolution of the cancer genome. Nat. Rev. Genet. 13, 795-806 (2012).
37. Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
38. Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002).
39. Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
40. Tabin, C. J. et al. Mechanism of activation of a human oncogene. Nature 300, 143-149 (1982).
41. Morgenstern, J. P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596 (1990).
42. Xiong, Y. et al. RNA sequencing shows no dosage compensation of the active X-chromosome. Nat. Genet. 42, 1043-1047 (2010).
43. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
44. Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nuclear Acids Res. 39, 945-950 (2010).
45. Benton, M. J. in The Adequacy of The Fossil Record (eds Donovan, S. K. and Paul C. R. C.) 269-303 (Wiley, 1998).
46. Morris, S. C. The fossil record and the early evolution of the MetazoaEvolutionary rate in the protein interaction network. Nature 361, 219-225 (1993).
47. Valentine, J. W., Erwin, D. H. & Jablonski, D. Developmental evolution of metazoan bodyplans: the fossil evidence. Science 296, 750-752 (2002).
48. Ryan, J. F. et al. The genome of the ctenophore Mnemiopsis leidyi and its implications for cell type evolution. Science 342, 1242592 (2013).
49. Rokas, A., Kruger, D. & Carroll, S. B. Animal evolution and the molecular signature of radiations compressed in time. Science 310, 1933-1938 (2005).
50. Parra, G. et al. Assessing the gene space in draft genomes. Nucleic Acids Res. 37, 289-297 (2009).
51. Storey, J. D. A direct approach to false discovery rates. J.R. Stat. Soc., Series B 64, 479-498 (2002).
52. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
53. Margulies, M. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380 (2005).
54. de Hoon, M. J. et al. Open source clustering software. Bioinformatics 20, 1453-1454 (2004).
55. Gautier, L. et al. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315 (2004).
56. Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449 (2005).